Glucose monitoring made easy with FreeStyle Libre 2 and 3 systems*1-2
Uncover hidden trends and patterns to get the complete picture†3.
Minute-to-minute readings
The Libre 2 and 3 systems provide information in real time, with new glucose readings every minute4,5.
Patterns and trends
Instead of time-consuming interpretations of blood glucose logs, your patients can quickly identify glycemic patterns and trends with sensor data†3.
Data storage
The Libre 2 and 3 systems provide the glycemic data you and your patients need†3. With the Libre 2 system, patients can use either the reader‡ or their smartphone§. The Libre 3 system automaticallyǁ sends readings directly to patients’ smartphones.
The Libre 2 and 3 systems continuously collect data4,5 so that you and your patients can make informed treatment decisions.
For illustrative purposes only.
Not actual patient data.
Real-time glucose information
Current glucose reading
Trend arrow
Indicates how glucose is changing
Glucose history
Up to the last 12 hours
Tools, including personal notes
Sensor life span
For illustrative purposes only.
Not actual patient data.
Trends and patterns
Easy access to glucose insights
Share reports with others
Data stored for up to 90 days
For illustrative purposes only.
Not actual patient data.
Optional, real-time glucose alarms¶
Customizable alarms
- Silent mode#
- Escalating alarms
- Vibration setting
Glucose alerts
Signal loss
The Libre App§ can also help patients make more confident food choices—thanks to Libre Assist**.
Libre Assist** is a free feature in the Libre App§ designed to support behavioral dietary change, one meal at a time. It’s there when you can’t be††, giving patients tips** to encourage healthier food choices in the moment.
- Snap
Patient takes a photo of their meal. - Predict
Libre Assist predicts how the food can impact‡‡ their glucose. - Know
Patients see the impact of food after they eat.
See how Libre Assist works now.
This is progress.
Glucose trend arrows are an important tool.
Glucose trend arrows show both the direction and the rate of change of a patient’s glucose readings, helping them interpret their readings more easily.
|
Current |
What trend arrow means |
Potential reading in 15 min |
|---|---|---|
|
110 |
Glucose is changing slowly |
— |
|
110 |
Glucose is rising quickly |
>140 mg/dL |
|
110 |
Glucose is rising |
125 to 140 mg/dL |
|
110 |
Glucose is falling |
80 to 95 mg/dL |
|
110 |
Glucose is falling quickly |
<80 mg/dL |
The Libre 2 and 3 systems make it easy for patients to monitor glucose*1,4,5.
Request your Libre 3 Plus sensor samples♢ today!
Get samples for your patients who could benefit from a CGM.
CGM = continuous glucose monitor(ing)
FreeStyle Libre 3 system is cleared to be used by children 4 years and older with Libre 3 sensor and 2 years and older with Libre 3 Plus sensor.
FreeStyle Libre 2 system is cleared to be used by children 4 years and older with Libre 2 sensor and 2 years and older with Libre 2 Plus sensor.
Medicare and other payor criteria may apply.
* Study was performed with the outside US version of the FreeStyle Libre 14 day system. Data is applicable to FreeStyle Libre 2 and 3 systems, as feature sets are similar as FreeStyle Libre 14 day system, excluding alarms.
† Study was performed with the US version of the FreeStyle Libre 14 day system. Data is applicable to FreeStyle Libre 2 and 3 systems, as feature sets are similar as FreeStyle Libre 14 day system, excluding alarms.
‡ The FreeStyle Libre systems apps and the FreeStyle Libre systems readers have similar but not identical features. Fingersticks are required for treatment decisions when you see Check Blood Glucose symbol and when your glucose alarms and readings from the system do not match symptoms or expectations.
§ The FreeStyle Libre systems apps are only compatible with certain mobile devices and operating systems. Please check the Support section of our website for more information about device compatibility before using the apps. Use of the FreeStyle Libre systems apps may require registration with LibreView.
ǁ The user’s device must have internet connectivity for glucose data to automatically upload to LibreView and to transfer to connected LibreLinkUp app users.
¶ Alarm notifications will only be received when alarms settings are enabled and turned on and sensor is within 20 feet (FreeStyle Libre 2 system) or 33 feet (FreeStyle Libre 3 system) unobstructed of the reading device.
# Silent mode allows users to silence their signal loss and glucose alarms, including urgent low glucose alarm for up to six hours. You will not hear your glucose and signal loss alarms even if you've turned on Override Do Not Disturb but may still get the visual and vibratory notifications based on your phone's settings.
** Libre Assist is a feature within Libre app that uses generative artificial intelligence to provide information on how foods could impact your glucose levels. Generative artificial intelligence may not always be accurate, and it should not be used to make treatment decisions.
†† Libre Assist is not intended to replace professional medical guidance, diagnosis, or treatment. It cannot be used as a substitute for professional healthcare advice.
‡‡ Predicted glucose impact is based on user-provided food data and may differ from actual impact, which depends on sensor readings and factors like activity, stress, medication, and alcohol.
§§ Sensor is water-resistant in up to 1 meter (3 feet) of water. Do not immerse longer than 30 minutes.
|||| The reader or smartphone must be near the sensor when scanning.
¶¶ Glucose readings are not available during 1-hour warm-up, when sensor is too hot or too cold, when you see an error “LO” or “HI” message, or no current glucose reading.
## Fingersticks are required if your glucose alarms and readings do not match symptoms or when you see Check Blood Glucose symbol during the first twelve hours.
*** Calibration or coding not required by the user.
♢ The sample is provided to you with no requirement or obligation.
References: 1. Haak, Thomas, et al. “Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-treated Type 2 Diabetes: a Multicentre, Open-label Randomised Controlled Trial.” Diabetes Therapy 8, no. 1 (2017): 55–73. https://doi.org/10.1007/s13300-016-0223-6. 2. Campbell, Fiona M., et al. “Outcomes of Using Flash Glucose Monitoring Technology by Children and Young People With Type 1 Diabetes in a Single Arm Study” Pediatric Diabetes 19, no. 7 (2018): 1294–1301. https://doi.org/10.1111/pedi.12735. 3. Unger, Jeff, Pamela Kushner, and John E. Anderson. “Practical Guidance for Using the FreeStyle Libre Flash Continuous Glucose Monitoring in Primary Care.” Postgraduate Medicine 132, no. 4 (2020): 305–313. https://doi.org/10.1080/00325481.2020.1744393. 4. FreeStyle Libre 2 User’s Manual. 5. FreeStyle Libre 3 User’s Manual. 6. Alva, Shridhara, et al. “Accuracy of a 15-Day Factory-Calibrated Continuous Glucose Monitoring System with Improved Sensor Design.” Journal of Diabetes Science and Technology (2025). https://doi.org/10.1177/19322968251329364. 7. Kesavadev, Jothydev, Lakshmy Ramachandran, and Gopika Krishnan. “Glucose Monitoring Technologies - Complementary or Competitive? Role of Continuous Glucose Monitoring Versus Flash Glucose Monitoring Versus Self-Monitoring of Blood Glucose.” Journal of Diabetology 8, no. 3 (2017): 61–67. https://journals.lww.com/jodb/fulltext/2017/08030/glucose_monitoring_technologies_complementary_or.1.aspx.
ADC-42704 v5.0
Important Safety Information
Failure to use FreeStyle Libre systems as instructed in labeling may result in missing a severe low or high glucose event and/or making a treatment decision, resulting in injury. If glucose reading and alarms (if enabled) do not match symptoms or expectations, use a fingerstick value from a blood glucose meter for treatment decisions. Get medical attention when appropriate. Abbott Customer Service at 855-632-8658 or visit FreeStyleLibre.us for safety info.
The product images are for illustrative purposes only.
No use of any Abbott trademark, trade name, or trade dress in this site may be made without prior written authorization of Abbott Laboratories, except to identify the product or services of the company.
This website and the information contained herein is intended for use by residents of the United States.
ADC-45115 v24.0